access to glp 1 medications New Medicare GLP-1 Bridge Program Launching July 1, 2026 GLP-1 Medications for Weight Loss:

Mechanism of Action: Why It Makes Sense for Athletes Sermorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile GH release and downstream insulin-like growth factor-1 (IGF-1) production. Growth hormone and IGF-1 influence several systems relevant to performance: Protein synthesis and muscle repair Collagen formation and tendon remodeling Lipolysis and metabolic efficiency Sleep architecture, particularly slow-wave sleep Because GH secretion is naturally highest during deep sleep, sermorelin is typically administered at night to align with this physiology

DEPOFORTE B12 AMP

Cavalu S, Damian G, Dnoreanu M

Beneficial microbes in the colon ferment the resistant starch

Results from a randomized cross-over study